Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
1.500
-0.020 (-1.32%)
Nov 18, 2026, 4:00 PM EST - Market closed
ZYBT Revenue
Zhengye Biotechnology Holding had revenue of 54.03M CNY in the half year ending December 31, 2025, a decrease of -43.00%. This brings the company's total for the last twelve months to 104.98M, down -31.71% year-over-year. In the year 2025, Zhengye Biotechnology Holding had annual revenue of 116.36M, down -37.56%. That makes Zhengye Biotechnology Holding the 35,299th largest company in the world by revenue and 4,632nd in the United States.
Revenue (ttm)
104.98M CNY
Revenue Growth
-31.71%
P/S Ratio
4.60
Revenue / Employee
390,264 CNY
Employees
269
Market Cap
71.09M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 116.36M | -69.99M | -37.56% |
| Dec 31, 2024 | 186.36M | -25.30M | -11.95% |
| Dec 31, 2023 | 211.65M | -48.62M | -18.68% |
| Dec 31, 2022 | 260.27M | 46.20M | 21.58% |
| Dec 31, 2021 | 214.07M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Organogenesis Holdings | 352.05M |
| Organigram Global | 217.71M |
| Akebia Therapeutics | 197.20M |
| Glass House Brands | 195.33M |
| InterCure | 84.76M |
| Journey Medical | 69.52M |
| BGM Group | 47.90M |
| Cumberland Pharmaceuticals | 46.29M |
ZYBT News
- 6 days ago - Zhengye Biotechnology Holding Limited Announces Financial Results for the First Six Months of Fiscal Year 2026 - PRNewsWire
- 3 months ago - Zhengye Biotechnology regains compliance with Nasdaq - TheFly
- 3 months ago - Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement - GlobeNewsWire
- 4 months ago - Zhengye Biotechnology Holding Ltd trading resumes - TheFly
- 4 months ago - Zhengye Biotechnology Holding Ltd trading halted, volatility trading pause - TheFly
- 4 months ago - Zhengye Biotechnology issues statement in response to unusual trading activity - TheFly
- 4 months ago - Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity - GlobeNewsWire
- 5 months ago - Zhengye Biotechnology receives deficiency notice over minimum bid price - TheFly